TMEM30A divergent transcript (TMEM30A-DT)

The TMEM30A divergent transcript (TMEM30A-DT) is annotated as a non-coding RNA or putative long non-coding RNA (lncRNA) gene related to the TMEM30A locus. Current research and gene databases, such as GeneCards and NCBI Gene, do not provide functional or therapeutic target information for TMEM30A-DT[7][3]. There is no evidence this transcript encodes a protein, participates in established biological pathways, acts as a disease biomarker, or is targeted by any drugs. Most scientific research and drug development discussions reference the protein-coding gene TMEM30A. The functions attributed to TMEM30A—including the regulation of phospholipid distribution and involvement in various human pathologies such as lymphoma and cholestasis—do not extend to TMEM30A-DT, which appears to have no experimentally established role as a receptor, enzyme, or pharmacological target[1][2][4][6][7]. At least one computational source speculates a possible function as a molecular scaffold in chromatin modification, but this remains unconfirmed and is purely hypothetical[3]. Key points: - There is no evidence that TMEM30A-DT is a validated or actionable therapeutic target. - No molecular function, druggability, or disease associations are established for this transcript in reputable databases as of 2025. - Most functional and disease research involves the protein-coding gene "TMEM30A", not "TMEM30A-DT". If you are interested in the function or therapeutic potential of TMEM30A (Transmembrane protein 30A), extensive information is available; for TMEM30A-DT, information is extremely limited and it is not recognized as a target[2][4][6][7].

Other names

TMEM30A-DTTMEM30A divergent transcript